Antimicrobial Susceptibility Test Practice Exam 2026 – Complete Prep Resource

Rapid diagnostics speed up the process of identifying the actual pathogen, so their reported impact is that time to identification is dramatically reduced. Traditional culture-based workflows can take a day or more because you must grow the organism and run various tests to determine the species. With rapid tools like MALDI-TOF, PCR-based panels, and other nucleic acid tests, identification can be achieved much sooner—often within hours after culture positivity or even directly from certain specimens. This accelerated ID allows clinicians to tailor therapy sooner, streamline antimicrobial stewardship, and potentially improve patient outcomes. It’s important to note that while rapid diagnostics speed up identifying what is causing the infection, they don’t always replace culture for all downstream work, such as comprehensive susceptibility testing, which still relies on culture in many settings.